Journal of Angiotherapy
Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
  1. You are here:
  2. Home
  3. Journals
  4. Journal of Angiotherapy

Editorial Structure

Editor-In-Chief(s) 

Fazlul Huq, Ph.D.
Retired Academic and Group Leader,  School of Medical Science, University of Sydney, Australia
Dr. Fazlul Huq is a distinguished scholar with a career spanning over five decades, recognized for his contributions to cancer research and drug discovery. As an Associate Professor at the University of Sydney’s School of Medical Sciences, he spearheaded innovative research on tumor-active metal complexes, drug-DNA interactions, and synergistic drug combinations aimed at overcoming platinum resistance in ovarian and colorectal cancers. Dr. Huq earned his PhD in Chemical Crystallography from University College London and held several prestigious roles, including ARC Postdoctoral Research Fellow and Group Leader of the Biomedical Science Cancer Research Group. He has authored over 312 peer-reviewed publications, accumulated more than 3,015 citations, and successfully supervised 26 PhD and 5 master’s students. A member of esteemed organizations such as the Royal Society of Chemistry, Dr. Huq’s legacy is defined by impactful teaching, pioneering research, and influential mentorship, leaving an indelible mark on the global scientific community.
 
 
Principal Scientist, R&D, Giner, Inc. United States
Dr. Muhit Rana is a leading expert in biosensors, nucleic acid nanotechnology, and point-of-care theranostics, with extensive experience in developing innovative diagnostics and therapeutic solutions. Currently serving as Principal Scientist in R&D at Giner, Inc., Dr. Rana has made significant contributions to liquid biopsy and biomarker research, advancing cancer diagnostics and precision medicine. He has authored over 20 impactful publications in high-impact journals, with over 600 citations, showcasing expertise in multiplexed activity analysis, hybridization chain reactions, and nanoparticle-enhanced drug delivery systems. His work includes groundbreaking studies on circulating oncomiRs, graphene oxide-based diagnostics, and ultrasensitive fungal gene detection. Dr. Rana's research is recognized globally for its innovative application of nanotechnology to healthcare challenges, bridging molecular science and practical clinical solutions. He continues to push the boundaries of biomedical science with a focus on transformative, accessible diagnostics and therapies.

 

Postdoctoral Research Associate, Michigan State University, United States
Dr. Md Nafiujjaman is a prominent researcher in nanomedicine, theranostics, and drug delivery systems. As a Research Associate at Michigan State University, his work focuses on developing cutting-edge contrast agents and nanotechnology-driven therapeutic strategies for precision medicine. Dr. Nafiujjaman has over 20 high-impact publications and 1,700 citations, reflecting his contributions to advanced biomedical applications such as graphene quantum dots, photo-chemo theranostics, and exosome-based diagnostics. His research bridges molecular nanotechnology with clinical innovation, offering transformative solutions in imaging, cancer therapy, and biomarker discovery. Recognized globally, Dr. Nafiujjaman’s work advances the field of nanomedicine and translational healthcare.
 
 
Executive Editors
 
VP, Neo7bioscience Inc., United States
Dr. Md Shamsuddin Sultan Khan is a distinguished researcher specializing in pharmacology, computational biology, cancer biology, transcriptomics, and medicinal chemistry. Currently associated with Neo7bioscience Inc. in the USA, his research spans diverse areas including angiogenesis, therapeutic drug design, and natural product pharmacology. Dr. Khan's impactful work is reflected in over 700 citations and multiple high-impact publications. His notable studies include investigations into anti-cancer therapies, bioactive compounds, and IL17A-targeted drug development. By integrating computational models and experimental biology, Dr. Khan advances precision medicine and translational research, contributing significantly to innovative therapeutic approaches and biopharmaceutical development.
 
Professor, Chairman, Eman Research Ltd, Canberra, Australia
Dr. Amin Malik Shah Abdul Majid is a renowned scientist specializing in botanical drugs, angiogenesis, cancer research, phytomedicine, and DNA-binding agents. Dr. Majid has made significant contributions to natural product-based therapeutics, anti-cancer drug discovery, and nanomedicine. Dr. Majid’s work has garnered over 3,500 citations, reflecting his impactful research in cancer biology, particularly the antiangiogenic and cytotoxic properties of natural compounds. His groundbreaking studies on essential oils, silver-based complexes, and xanthones have advanced innovative approaches to cancer treatment and translational medicine.
 
 
Section Editors
 
Molecular Biology, Cancer, Angiogenesis
Senior Scientist, AstraZeneca Inc., United States 
Dr. Loiy Esir Ahmed Hassan is a Scientist II AstraZeneca. He is a researcher in cancer biology, drug discovery, tumor angiogenesis, and preclinical pharmacology. His innovative work bridges the gap between natural product-based therapeutics and cancer therapy. With over 1,500 citations, Dr. Hassan has made significant strides in understanding the anticancer and anti-inflammatory properties of natural compounds, including cucurbitacins and essential oils. His research explores molecular mechanisms of tumor suppression, targeting pathways such as angiogenesis and apoptosis, advancing novel chemotherapeutic strategies. Dr. Hassan’s work continues to impact cancer treatment and translational medicine globally.
 
Postdoctoral Associate, University of Alberta, Canada
Dr. Yasser Tabana is working as biochemist at the University of Alberta, specializing in cancer immunotherapy and biochemistry. His research focuses on the molecular mechanisms underlying cancer progression, emphasizing natural compounds' anticancer, antioxidant, and antimicrobial properties. Dr. Tabana has contributed significantly to the development of small molecule inhibitors targeting PD-L1, a crucial immune checkpoint in cancer therapy. His work also explores the therapeutic potential of essential oils and plant extracts in treating cancer and other diseases. With numerous publications and citations, Dr. Tabana’s research continues to impact the fields of immunotherapy and drug discovery.
 
Bioinformatics, Data modeling, Engineering
Senior Research Scientist, Indiana University, United States
Dr. Vishwanadham Mandala is a leading expert in big data, AI, machine learning, and data engineering, with significant contributions to data science and analytics. Currently serving as Enterprise Architect - Data at Cummins, he focuses on AI-driven solutions in automotive safety, manufacturing, and predictive maintenance. Dr. Mandala has authored numerous papers on topics like AI-based recommendation models, predictive failure analytics, and real-time engine failure prediction. His research also explores big data lake houses, data integration, and optimizing supply chains, making him a recognized figure in the field of advanced data analytics and artificial intelligence.
 
Medical Biochemistry, Immunology, Cancer
Australian National University, Australia
Emeritus Professor Chris Parish is an immunologist and leader of the Cancer and Vascular Biology Group at ANU's John Curtin School of Medical Research. He earned his PhD at The Walter & Eliza Hall Institute and has spent over 35 years advancing immunology. In the 1970s, he was the first to demonstrate the antagonistic relationship between cell-mediated immunity and antibody formation, a discovery central to the Th1/Th2 paradigm. His work on heparan sulfate and heparanase has led to the development of novel anti-cancer therapies, including PI-88. In 2005, he received the prestigious Ramaciotti Medal for Excellence in Biomedical Research for his groundbreaking contributions.
 
Infectious Disease
Postdoctoral Associate, Mount Sinai Hospital, United States
Dr. Mohammad Mamun Alam is a Postdoctoral Fellow in the Division of Infectious Disease at Icahn School of Medicine, Mount Sinai Hospital. His research focuses on virology, immunology, and molecular microbiology. Dr. Alam has contributed to the development of novel multi-epitope vaccines, including work on the Nipah Virus and SARS-CoV-2 variants. He has also conducted research on immune responses to COVID-19 vaccines in Bangladesh and studied antiviral activities against Dengue Virus. His expertise extends to molecular epidemiology, multidrug-resistant tuberculosis detection, and HIV-1 inhibition. Dr. Alam’s work has significantly advanced our understanding of infectious diseases and immune responses.
 
Clinical, Health, Molecular Biology, Cancer, Angiogenesis
Clinical Research Associate, CTI Clinical Trial Services, Australia
Dr. Mohamed Khadeer Ahamed is a Clinical Research Associate II at CTI Clinical Trial and Consulting Services in Sydney, Australia, with over 15 years of experience in clinical research. A biochemist and pharmacologist, his expertise spans oncology, diabetes, and preclinical toxicology studies. Dr. Ahamed has contributed significantly to cancer biology, angiogenesis, and experimental pharmacology, focusing on natural products like Aquilaria crassna and Ficus deltoidea. He holds a PhD in Pharmacology from Kuvempu University and has authored several key papers on the anticancer, antioxidant, and antimicrobial properties of natural compounds, driving innovation in drug development and cancer research.
 
Aman Shah Bin Abdul Majid, Ph.D.
Professor, Quest International University, Malaysia
Prof. Dr. Aman Shah Abdul Majid, FRSB, is a distinguished academic and researcher in the Faculty of Medicine at the Centre for Angiogenesis and Natural Product Research. His work focuses on clinical research, natural product screening, angiogenesis, cell signaling, and neuroprotection. With expertise in cancer, antioxidant, and antimicrobial properties, Dr. Majid has contributed to numerous groundbreaking studies on medicinal plants, including Aquilaria crassna and Illicium verum. His research has been widely cited, and he has authored influential papers on the therapeutic potential of natural products. Dr. Majid is a prominent figure in pharmacology, advancing both fundamental and applied research.
 
Simin Li, Ph.D.
Professor, Southern Medical University, China
Dr. Simin Li is a Professor at the Stomatological Hospital, Southern Medical University, specializing in dentistry and molecular biology. Her research focuses on oral squamous cell carcinoma, periodontitis, and the role of long non-coding RNAs (lncRNAs) in these conditions. Dr. Li has contributed to significant studies exploring the molecular mechanisms underlying oral diseases, antimicrobial peptides, and cancer progression. She has co-authored numerous high-impact papers, including research on miRNA networks in periodontitis and oral cancer, and has become a key figure in advancing diagnostic and therapeutic strategies in oral health.
 
Analytical Chemistry
Associate Professor, University of Agriculture Faisalabad, Pakistan
Dr. Muhammad Adnan Iqbal is an Associate Professor in the Department of Chemistry at the University of Agriculture Faisalabad. His research spans organometallics, coordination chemistry, and medicinal and environmental chemistry. Dr. Iqbal has made significant contributions to the development of silver-based complexes with anticancer, antioxidant, and antimicrobial properties. His studies also focus on the synthesis of novel metal complexes for biomedical applications, particularly in cancer treatment. Dr. Iqbal has co-authored over 80 publications in leading journals, advancing the field of coordination chemistry and its potential applications in medicine and environmental science.
 
Natural Product, Molecular Biology, Analytical Chemistry
Postdoctoral Research Associate, Edith Cowan University, Australia
Dr. Armaghan Shafaei is a postdoctoral researcher at the School of Science, Edith Cowan University (ECU). His expertise lies in phytochemistry, analytical chemistry, and toxicology, focusing on the medicinal properties of plant extracts and their applications in chronic disease prevention and cancer therapy. Dr. Shafaei's notable contributions include studies on Ficus deltoidea and Mesua ferrea, exploring their genotoxicity, anticancer, and antioxidant potentials. His work also advances analytical techniques, such as LC-MS/MS, for biomarker quantification in clinical research. With over 20 high-impact publications, Dr. Shafaei continues to innovate in natural product research and its integration into therapeutic strategies.
 
Associate Professor, TISHK International University, Iraq
Dr. Ahmad Hamdy Ibrahim is a leading researcher and Associate Professor at Tishk International University, specializing in molecular medicine, pharmacology, and genetics. His interdisciplinary work bridges natural product chemistry, toxicology, and cancer research. Dr. Ibrahim has made significant contributions to studying bioactive compounds, including the anticancer properties of Terfezia claveryi (black truffle) and the therapeutic potential of Aquilaria malaccensis oil. His research extends to analytical chemistry, supercritical fluid extraction, and sustainable methodologies. With numerous high-impact publications, he has advanced our understanding of natural remedies, angiogenesis, and wound healing. Dr. Ibrahim’s innovative approaches aim to improve public health and translational medical applications.
 
Muhammad Asif, Ph.D.
The Islamia University of Bahawalpur, 
Pakistan
 
Engineering
Noman Hossain, Ph.D.
Primeasia University,
Bangladesh
 
Literature, Social Science, Health 
Sharif Mohammad Shahidullah, Ph.D.
International Islamic University
Malaysia
 
Professor, Universiti Teknologi MARA Malaysia, Malaysia
Professor Dr. Abdul Kadir Othman is a distinguished scholar at the Faculty of Business and Management, Universiti Teknologi MARA Malaysia. Specializing in organizational psychology, customer service management, and Islamic marketing, he has made significant contributions to understanding leadership styles, employee engagement, and customer satisfaction. His research spans diverse topics, including loyalty programs, service recovery, and the intersection of Islamic principles with modern business practices. A prolific author, Professor Othman has numerous high-impact publications that explore innovative frameworks for improving organizational performance and customer experience. His work combines academic rigor with practical insights, influencing both academia and industry practices.
 
Virology and Infectious Diseases
Md Haroon Or Rashid, MS
Doctoral student, Kagoshima University, Japan
Md Haroon Or Rashid is a Doctoral student at Kagoshima University, Japan, specializing in virology, vaccinology, and infectious diseases. His research primarily focuses on hepatitis B virus, dengue, and antibiotic resistance, with a notable emphasis on public health issues in Bangladesh. His studies have contributed to understanding antimicrobial resistance in Salmonella and Escherichia coli, the seroprevalence of chikungunya, and immune responses to viral infections. Haroon has also explored innovative antiviral therapies, such as the suppression of dengue virus replication using natural extracts. His work bridges clinical microbiology and global health challenges, aiming to mitigate the spread of infectious diseases. 
 
 
Associate Editors
Professor, Al-Nahrain University, Iraq
Dr. Hayder B. Sahib is a Professor specializing in pharmacology and toxicology at Al-Nahrain University, Iraq. His research explores the pharmacological potential of medicinal plants, focusing on their anti-angiogenic, antioxidant, and anti-proliferative properties. He has extensively studied Orthosiphon stamineus, Vitex agnus-castus, and Phoenix dactylifera for their therapeutic applications in cancer, hyperlipidemia, and toxicity management. Professor Sahib's work bridges traditional medicine and modern pharmacological approaches, contributing significantly to understanding natural compounds in combating diseases. His publications have been widely cited, reflecting his impact on advancing natural product pharmacology and its application in treating complex health conditions.
 
Mostafa Alamholo, Ph.D.
Lecturer, Rojava University, Syria
Dr. Mostafa Alamholo is a researcher specializing in biotechnology and bioinformatics, with a strong focus on natural product research and plant-derived bioactives. His work explores the antibacterial, antioxidant, and phytochemical properties of various medicinal plants, including Citrus medica, Thymus spp., and Pistacia atlantica. He has contributed to understanding molecular mechanisms of stress tolerance in crops like barley (Hordeum vulgare), combining transcriptomic and meta-analytical approaches. Dr. Alamholo’s studies are widely recognized for their application in pharmacology, sustainable agriculture, and microbial resistance. Despite limited affiliation visibility, his interdisciplinary work addresses critical challenges in microbiology and medicinal plant research.
 
Lecturer, Erciyes University, Turkey
Dr. Muhammed Ihsan Han, a faculty member at Erciyes University, specializes in medicinal chemistry, focusing on the design and synthesis of bioactive compounds. His research primarily explores hydrazide-hydrazones, thiosemicarbazides, and naproxen derivatives for their anticancer, antimicrobial, and anti-inflammatory properties. Dr. Han’s innovative studies integrate molecular docking, in vitro, and in vivo evaluations, advancing targeted therapies, particularly for breast and colon cancer. With over 100 citations for his impactful publications, he contributes significantly to medicinal chemistry, emphasizing sustainable drug discovery. His dedication to interdisciplinary approaches and novel therapeutic agents makes him a leading researcher in pharmacological innovation.
 
Medical Physicist, Aqaba University of Technology, Jordan
Dr. Abdulsalam Ali Abuelsamen, a distinguished Medical Physics expert at Aqaba University of Technology, focuses on advancing medical nanotechnology, photodynamic therapy, and radiography applications. His pioneering research integrates nanomaterials, such as ZnO nanorods and silica nanoparticles, for use in photodetectors, biosensors, and cancer therapies. With extensive contributions in nanostructure synthesis and characterization, he has significantly impacted UV detection, hydrogen sensing, and photodynamic treatment for osteosarcoma and bladder cancer. Dr. Abuelsamen’s interdisciplinary approach bridges material science and medical applications, driving innovations in theranostic technologies and personalized medicine. His work reflects a commitment to sustainable and impactful advancements in healthcare.
 
Associate Professor, Western Sydney University, Australia
Dr. Christopher Cazzonelli, an Associate Professor of Plant Molecular Biology at the Hawkesbury Institute for the Environment, is a globally recognized expert in carotenoid regulation, epigenetics, and plant stress responses. His pioneering research explores the intricate regulation of carotenoid biosynthesis and its implications for plant development, environmental adaptability, and horticultural productivity. Dr. Cazzonelli has made significant contributions to understanding chromatin modification, apocarotenoid signaling, and mechanical stress in plants, bridging molecular biology and applied agriculture. His groundbreaking work on carotenoids extends to tree genomics and shorticulture, emphasizing sustainability and resilience in plant systems. His studies have garnered widespread acclaim and high citations, reflecting his impactful scientific contributions.
 
Postdoctoral Researcher, The University of Adelaide, Australia
Dr. Zeyad D. Nassar is a distinguished researcher in Cancer Biology at the University of Adelaide’s School of Medicine. His expertise spans angiogenesis, lymphangiogenesis, and natural product-based drug discovery. Dr. Nassar has made pivotal contributions to understanding the molecular mechanisms of prostate cancer, including fatty acid metabolism and the role of lipidomic alterations in cancer progression. His work also explores the antioxidant and antiangiogenic activities of medicinal plants. With numerous impactful publications, Dr. Nassar's research continues to advance the development of targeted therapies and natural product-based treatments in oncology.
 
Associate Professor, Universiti Sains Malaysia, Malaysia
Dr. Yam Mun Fei, is an Associate Professor at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, in pharmacology. His research focuses on pain regulation, anti-inflammatory agents, antioxidant activity, and natural product pharmacology. Dr. Yam has made significant contributions to understanding bioactive compounds from plants such as Orthosiphon stamineus and Gynura procumbens, advancing their applications in diabetes, inflammation, and hepatoprotection. His impactful studies, often cited globally, include groundbreaking insights into the pharmacological properties of flavonoids and terpenoids. Dr. Yam’s work bridges traditional medicinal knowledge with modern drug discovery, solidifying his role in advancing pharmaceutical sciences.
 
Associate Professor, Universiti Sains Malaysia, Malaysia
Dr. Nozlena Abdul Samad, is a Associate Professor at Universiti Sains Malaysia, specializes in cancer research, angiogenesis, and phytomedicine. Her pioneering work explores the anticancer potential of natural compounds, particularly through innovative drug delivery systems and nanomedicine. Dr. Samad’s notable studies on Moringa oleifera and Zerumbone have elucidated their mechanisms in suppressing tumor growth and angiogenesis. With a strong focus on the biomedical applications of plant-based therapies, she bridges traditional medicine with modern therapeutic advancements. Renowned for her systematic reviews and translational research, Dr. Samad’s contributions have significantly enriched the field of phytopharmacology and novel anticancer strategies.
 
William E. Feeman, MD
Principal Investigator, The Bowling Green Study Center, United States
Dr. William Feeman, MD, is the Principal Investigator of The Bowling Green Study, focusing on lipid metabolism, atherosclerosis, and metabolic diseases. With over 100 publications and a significant research impact, Dr. Feeman's work explores key risk factors for atherothrombotic disease (ATD), including the Cholesterol Retention Fraction's predictive power compared to LDL-cholesterol. His studies emphasize the importance of lipid management in disease prevention and treatment, including long-term statin therapy outcomes. Dr. Feeman’s expertise spans insulin resistance, glucose metabolism, hypertension, and diabetes, making him a prominent figure in cardiovascular and metabolic disease research.
 
Bhisma Narayan Ratha, Ph.D.
Assistant Professor, Centurion University of Technology and Management, India
Dr. Bhisma Narayan Ratha, Assistant Professor at Centurion University of Technology and Management, is a leading researcher in protein biochemistry, biophysics, and phytochemistry. His groundbreaking work focuses on understanding amyloid fibrillation, particularly in insulin and α-synuclein, with implications for neurodegenerative diseases and diabetes. Dr. Ratha's contributions to the study of protein aggregation mechanisms, membrane interactions, and therapeutic peptide development have garnered significant recognition. His innovative approaches to inhibiting amyloid formation and biofilm growth highlight his interdisciplinary expertise in nanomedicine and therapeutic biochemistry. Through his prolific publications, Dr. Ratha has advanced the fields of molecular biology and translational medicine.
 
Nephrologist, Alexandria University, Egypt
Dr. Yaser Aly Ammar, MD, is a distinguished nephrologist at the Medical Research Institute, Alexandria University. With expertise in nephrology, internal medicine, and human biology, Dr. Ammar’s research focuses on bioinformatics, computational biology, and renal biopsy techniques. His scholarly contributions, encompassing 25 publications with over 4,000 reads and numerous citations, underscore his commitment to advancing kidney health and innovative diagnostic approaches. Dr. Ammar combines clinical expertise with cutting-edge bioscience methodologies, making significant strides in understanding renal diseases and improving patient outcomes. His work continues to inspire collaborations within the global scientific community.
 
Oon Chern Ein, Ph.D.  
Associate Professor, Oncologist Universiti Sains Malaysia, Malaysia
Dr. Chern Ein Oon is a molecular Oncologist at INFORMM, Universiti Sains Malaysia, specializing in targeted cancer therapies, Notch signaling, and tumor angiogenesis. Her impactful research, reflected in over 1,000 citations for her seminal work on molecular therapies, has advanced the understanding of cancer mechanisms and therapeutic strategies. Dr. Oon’s expertise extends to sirtuins and bioactive compound analysis, contributing to innovative approaches in combating tumorigenesis and metastasis. With a prolific academic record, she has co-authored groundbreaking studies on exosomal signaling, VEGF resistance, and apoptosis modulation, establishing herself as a leader in precision oncology and translational cancer research.
 
Doctoral Student, Universiti Sains Malaysia, Malaysia
Siti Balkees STN Hameed Sultan is a doctoral student at the Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia (USM). Her research focuses on clinical trials, pharmacokinetics, and bioavailability, with an emphasis on enhancing drug delivery systems. She has co-authored publications on innovative drug designs, including fused-ring 1,2,4-triazole derivatives with antitumor activity and phospholipid-encapsulated herbal extracts for angiotherapy. Siti Balkees is particularly interested in addressing skin barrier challenges in dermal and transdermal drug delivery. Her work contributes to advancing pharmaceutical sciences through novel therapeutic approaches and improved drug formulation techniques.
 
Associate Professor, University of Jordan, Jordan
Dr. Malek Zihlif, a faculty member in the Department of Pharmacology at the University of Jordan, specializes in pharmacogenomics, cancer biology, and drug resistance. He investigated the genetic and molecular mechanisms underlying cancer progression, with significant contributions to understanding doxorubicin resistance and hypoxia-induced gene expression in breast cancer. Dr. Zihlif has explored innovative anticancer therapies, including bioactive compounds and liposomal drug delivery systems, earning widespread recognition with nearly 200 citations for his pioneering study on MCF7 cell lines. A prolific researcher, he actively collaborates on projects advancing personalized medicine and novel therapeutic strategies in oncology and pharmacology.
 
Assistant Professor, Sohar University, Sultanate of Oman
Dr. Ali F. Jameel is an Assistant Professor at the Faculty of Education and Arts, Sohar University, Sultanate of Oman. His research expertise lies in fuzzy mathematics, differential equations, and numerical and approximation methods. Dr. Jameel has made significant contributions to solving complex mathematical problems, including fuzzy differential equations, boundary value problems, and delay differential equations, often employing innovative techniques like homotopy and numerical analysis. With numerous publications in high-impact journals, his work addresses theoretical advancements and practical applications in physics and engineering. Dr. Jameel is recognized for his collaborative and analytical approach, advancing computational mathematics in diverse domains.
 
Elham Farsi, Ph.D.
Universiti Sains Malaysia, Malaysia
Dr. Elham Farsi is a researcher at Universiti Sains Malaysia specializing in pharmacology. Her work focuses on natural product safety, genotoxicity, and pharmacological efficacy, particularly in medicinal plants like Hylocereus polyrhizus and Ficus deltoidea. She has conducted comprehensive toxicity studies and explored bioactive compounds for their therapeutic potential, including anti-cancer, lipid-lowering, and insulin-regulating effects. Elham's notable contributions include pioneering research on standardized plant extracts and nanotechnology-based drug delivery systems. With a strong publication record in reputable journals, her studies bridge traditional medicine and modern pharmacological applications, advancing natural therapeutics' safety and efficacy for chronic disease management.
 
Associate Professor, Rustaq College, Oman
Dr. Saad Sabbar Dahham is an Associate Professor, at the University of Technology and Applied Sciences, Rustaq, Oman, specializing in cancer biology and microbiology. His work focuses on natural compounds with anticancer, antimicrobial, and antioxidant properties, particularly from Aquilaria crassna, Punica granatum, and Terfezia claveryi. Dr. Dahham's research has significantly contributed to understanding bioactive essential oils and their therapeutic applications, including β-caryophyllene's potential in cancer treatment. With a robust publication record in leading journals, his studies bridge molecular biology, pharmacology, and traditional medicine, advancing innovative strategies for cancer prevention and treatment through natural and sustainable approaches.
 
Senior Scientist, Universiti Sains Malaysia, Malaysia
Dr. Fouad Saleh Resq Al-Suede is a Scientist in the field of pharmacology, experimental medicine, and advanced nutraceuticals. His work focuses on antiangiogenesis, cancer pathways, and the therapeutic potential of natural products. Dr. Al-Suede has made significant contributions to isolating and characterizing bioactive compounds from medicinal plants such as Kaempferia galanga and Orthosiphon stamineus. His research has elucidated molecular mechanisms underlying anti-inflammatory, anticancer, and pro-apoptotic effects, advancing innovative strategies for cancer treatment. With numerous high-impact publications, Dr. Al-Suede continues to bridge pharmacology and natural medicine, fostering novel approaches in oncology and precision therapeutics.
 
Associate Professor, Quest International University, Malaysia
Dr. M. M. Kanakal is an Associate Professor in Pharmaceutics and Pharmaceutical Technology at QIU, specializing in drug formulation, pharmacology, and pharmaceutical analysis. His research focuses on the development of novel drug delivery systems, including nanoemulsions for topical delivery, and the evaluation of various drug compounds for their anticancer, anti-inflammatory, and antimicrobial properties. Dr. Kanakal has contributed significantly to the study of ketoprofen, piroxicam, and essential oils, with numerous publications on drug solubility, permeability, and bioavailability. His work also explores the use of analytical techniques like HPLC and UPLC for drug analysis and quality control.
 
Professor University of Basrah, Iraq
Professor Dr. Mouayed A. Hussein is a distinguished academic in the fields of photochemistry, inorganic chemistry, and medicinal chemistry. He holds a professorship at the University of Basrah, Iraq, and has made significant contributions to the synthesis and characterization of metal complexes with biological applications. His research focuses on the anticancer, pro-apoptotic, and anti-metastatic properties of metal-based complexes, particularly binuclear silver(I)–N-heterocyclic carbene complexes. Prof. Hussein's work has resulted in multiple publications in high-impact journals, highlighting his expertise in DNA binding, cleavage, and antitumor activities. He continues to explore innovative approaches in the development of therapeutic agents.
 
Postdoctoral Researcher, Riphah International University, Pakistan
Dr. Sadia Sarwar is a postdoctoral researcher at Riphah International University, specializing in pharmacognosy. She holds a Ph.D. and M.Phil. in Plant Physiology, with a strong foundation in molecular biology and biotechnology. Her research expertise includes DNA extraction, gel electrophoresis, PCR, cell culture, and tissue culture techniques. Dr. Sarwar is actively involved in exploring plant-based compounds for medicinal purposes, contributing to the field with her knowledge of DNA isolation and purification. With a focus on advancing pharmacognosy, her work aims to bridge plant sciences and modern therapeutic applications. She has published several research articles and continues to collaborate within the scientific community.
 
Postdoctoral Researcher, Alzahra University, Iran
Dr. Fatemeh Jafari is a postdoctoral researcher at Al-Zahra University, specializing in pharmacology, angiogenesis, and medicinal plants. Her research focuses on the anticancer properties of natural products and their mechanisms of action, including pro-apoptotic, anti-metastatic, and anti-angiogenic effects. Dr. Jafari has contributed to several studies on plant-based therapies, with a particular interest in enhancing the solubility and bioavailability of natural compounds for cancer treatment. Her work has been published in leading journals, and she continues to explore innovative strategies in ethnopharmacology and the development of novel anticancer agents derived from medicinal plants.
 
Management and Science University, Malaysia
Dr. Jegathambigai Rameshwar Naidu is a researcher at Management and Science University (MSU) specializing in medicinal plants. His work focuses on the bioactive properties of plant extracts, including their antimicrobial, antioxidant, antihyperglycemic, and anticancer activities. Dr. Naidu has contributed extensively to research on traditional herbs, such as Mentha spicata and Carica papaya, exploring their therapeutic potential in treating various diseases. His studies also include the toxicological profiles of plant extracts and their pharmacological effects. With numerous publications in reputable journals, Dr. Naidu is dedicated to advancing herbal medicine and its applications in modern healthcare.
 
Associate Professor, Management and Science University, Malaysia
Dr. Mahfoudh Abdulghani is an academic and researcher affiliated with Management and Science University (MSU), Malaysia, and the University of Science and Technology, Yemen. His work focuses on the pharmacology of the female reproductive system, with extensive research on medicinal plants and their therapeutic applications. Dr. Abdulghani has published numerous studies, including on the effects of Eurycoma longifolia and Mentha spicata in reproductive health, as well as on the perceptions of students regarding generic medicines. His contributions span areas such as cancer therapy, antimicrobial activity, and environmental health, making him a leader in his field.
 
Associate Professor, Al-Hussein Bin Talal University, Jordan
Dr. Sultan Ayesh Mohammed Saghir is an associate professor in the Department of Medical Analysis at Princess Aisha Bint Al-Hussein College of Nursing and Medical Sciences. His research primarily focuses on hematology, blood banking, and natural products. Dr. Saghir has made significant contributions to the understanding of oxidative stress, inflammation, and the therapeutic potential of various natural compounds. His studies include the effects of galangin, formononetin, and Averrhoa carambola on liver injury, kidney protection, and antimicrobial activity. He is also involved in exploring prebiotics' role in controlling Salmonella in poultry and improving heat stress resistance in livestock.
 
Lecturer, Universiti Malaysia Sarawak, Malaysia
Dr. Majed Ahmed Al-Mansoub is a university lecturer at the Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak. His research interests include applied biochemistry, pharmacology, toxicology, pharmacognosy, and phytochemical screening. Dr. Al-Mansoub has contributed extensively to studies on the anticancer properties of medicinal plants, such as Illicium verum and Garcinia atroviridis, as well as evaluating the toxicity and therapeutic effects of plant extracts. He has also focused on the molecular mechanisms behind cell death, anti-inflammatory activities, and cardiovascular protection. His work aims to enhance the understanding of natural products for drug development and disease prevention.
 
Science Officer, Universiti Sains Malaysia, Malaysia
Dr. Mohammad Razak Hamdan is a Science Officer at the Centre of Drug Research, Universiti Sains Malaysia. He specializes in herbal extraction, chromatography, spectroscopy, and multivariate data analysis. His research focuses on the analytical study of plant bioactives, including the identification and quantification of phenolic compounds, antioxidants, and antimicrobial activities in medicinal plants. Dr. Hamdan has contributed significantly to the development of methods for profiling plant metabolites and studying their biological activities, particularly in relation to cancer, antioxidants, and cytotoxicity. His work aims to enhance the pharmaceutical potential of natural products for therapeutic applications.
 
Tufael, Ph.D.
Clinical Biochemist,  Parul University, India
Dr. Tufael, a clinical biochemist at Parul University, specializes in biochemistry, molecular biology, liver cancer research, public health, and microbiology. His work emphasizes the early diagnosis of hepatocellular carcinoma through biomarkers such as AFP, CA19-9, and CEA. With a keen interest in public health challenges, he has contributed to studies on antibiotic-resistant infections, nutrient evaluations, and the metabolic effects of Nigella sativa and Syzygium cumini. Dr. Tufael has also investigated the role of serum zinc and calcium in psoriasis and the diagnostic significance of troponin I in septic patients. His multidisciplinary research bridges clinical insights and innovative healthcare solutions.
 
Assistant Professor, Andhra Loyola College, India.
Dr. SK. Chand Basha, FTE, serves as an Assistant Professor in the Department of Zoology at Andhra Loyola College (Autonomous), India. His research spans neurosciences, microbial technology, and bioinformatics, with a strong focus on Alzheimer's disease, mangrove ecosystems, and microbial bioactives. Dr. Basha’s contributions include insights into the role of TREM2 in Alzheimer's pathophysiology, computational docking studies for therapeutic applications, and the bioactivity of mangrove-derived actinomycetes. His interdisciplinary work extends to sustainable development, geopolitical studies, and renewable energy. An accomplished academic, Dr. Basha has published extensively, offering valuable contributions to both environmental conservation and medical science research.
 
Lecturer, Universitas Muhammadiyah Surakarta, Indonesia
Agus Dwianto is a lecturer and researcher specializing in innovation analysis, sustainability, and corporate governance. Affiliated with Universitas Muhammadiyah Surakarta, he actively contributes to academic discourse through Scopus and Web of Science-indexed publications. His work explores diverse themes, including environmental accounting, fraud detection, board gender diversity, and Islamic economic empowerment. Agus’s research spans global issues such as sustainable business practices, digital entrepreneurship, and macroeconomic impacts of international trade regulations. With notable studies on sustainability and financial performance, he provides valuable insights into aligning corporate governance with environmental and social responsibilities, promoting ethical practices and long-term value creation.
 
Md. Fakruddin, Ph.D. 
Associate Professor, North South University, Bangladesh
Dr. Md Fakruddin is an Associate Professor at the Department of Biochemistry & Microbiology, North South University, Dhaka, Bangladesh. His research spans hematopoiesis, stem cell biology, mitochondrial biology, tRNA modification, and microbiology. Dr. Fakruddin has made significant contributions to nanobiotechnology, biosurfactants, and alternative nucleic acid amplification methods. His work also includes antimicrobial and antioxidant activity studies of probiotics, along with predictive microbiology in food safety. With a focus on microbial community diversity and mitochondrial diseases, Dr. Fakruddin is dedicated to advancing our understanding of biotechnology's potential in medicine and environmental applications.
 
 
Advisory Committee
University of New South Wales (UNSW), Australia
Dr. Laurence Patrick George Wakelin is an Honorary Associate Professor at the School of Chemistry, University of New South Wales, Australia. Renowned for his expertise in drug discovery, cancer pharmacology, molecular pharmacology, and DNA-ligand interactions, Dr. Wakelin has significantly advanced the understanding of DNA-targeting agents. His research encompasses bifunctional intercalating antibiotics, DNA-binding kinetics, and the design of novel anticancer agents, including acridine-based compounds. With numerous influential publications in top journals, his work bridges molecular biology and medicinal chemistry, focusing on innovative therapeutic approaches for cancer. Dr. Wakelin's contributions have shaped modern strategies in precision pharmacology and DNA-directed drug development.
 
Amin Malik Shah Abdul Majid, Ph.D.
Eman Research Ltd
Australia
 
Emeritus Professor Christopher Parish, Ph.D.
Australian National University,
Australia
 
 

Publication & Editorial Staff Contacts


Publisher 

  • Rafath E Rouf, Email: office@emanresearch.org

 

For Advertising, Commercial Reprint, and/or Recruitment Information

  • Visit ER's Advertising Center

Marketing Manager

  • office@emanresearch.org

 

Translation, Rights & Licensing

  • office@emanresearch.org


Eman Research Business Offices 

Eman Research Publishing LLC, 30 N Gould St Ste R Sheridan, WY 82801 USA
https://www.emanresearch.org


Submit Article

Use the online submission system to send us your manuscript.


Call for Papers

We are seeking Contributions for a special issue.  More.


Best Paper Award

Authors are awarded for Best Paper for this Journal Annually


Advertisement

Journal of Angiotherapy